This biopharma is developing novel cancer treatments for patients suffering from recurring and metastatic cancer. Shares were trading up after the firm announced that a Certificate of Grant for...

To read the full story on AllPennyStocks.com, click here.

Propanc Biopharma (PK) (USOTC:PPCB)
過去 株価チャート
から 6 2024 まで 7 2024 Propanc Biopharma (PK)のチャートをもっと見るにはこちらをクリック
Propanc Biopharma (PK) (USOTC:PPCB)
過去 株価チャート
から 7 2023 まで 7 2024 Propanc Biopharma (PK)のチャートをもっと見るにはこちらをクリック